VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
BLLNBillionToOne, Inc.$101.12$4.7B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

BLLN logoBillionToOne, Inc.(BLLN)Earnings, Financials & Key Ratios

BLLN•NASDAQ
1564.4× P/E·Price updated Jun 11, 2026
  • Revenue$305M+100.0%
  • EBITDA$16M+145.2%
  • Net Income$7M+117.9%
  • EPS (Diluted)0.06+106.8%
  • Gross Margin68.32%+28.8%
  • EBITDA Margin5.25%+122.6%
  • Operating Margin5.25%+117.0%
  • Net Margin2.44%+109.0%
  • ROE2.3%+105.5%
  • ROIC13.45%+131.4%
  • Debt/Equity0.23-65.2%
  • Interest Coverage168.66+1127.8%

BLLN Key Insights

BillionToOne, Inc. (BLLN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong Piotroski F-Score: 7/9
  • ✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when BLLN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

BLLN Price & Volume

BillionToOne, Inc. (BLLN) stock price & volume — 10-year historical chart

Loading chart...

BLLN Growth Metrics

BillionToOne, Inc. (BLLN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-

Return on Capital

10 Years-25.19%
5 Years-25.19%
3 Years-25.19%
Last Year3.73%

BLLN Recent Earnings

BillionToOne, Inc. (BLLN) EPS & revenue vs analyst estimates — last 3 quarters

Full history →
●Beat EPS 2/3 qtrs (67%)●Beat Revenue 3/3 qtrs (100%)
Q2 2026Latest
May 6, 2026
EPS
$0.34
Est $0.03
+981.8%
Revenue
$108M
Est $97M
+11.6%
Q2 2026
Mar 4, 2026
EPS
$0.11
Est $0.07
+57.1%
Revenue
$96M
Est $87M
+10.2%
Q4 2025
Dec 9, 2025
EPS
$0.10
Est $0.14
-28.3%
Revenue
$84M
Est $83M
+0.8%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.34vs $0.03+981.8%
$108Mvs $97M+11.6%
Q2 2026Mar 4, 2026
$0.11vs $0.07+57.1%
$96Mvs $87M+10.2%
Q4 2025Dec 9, 2025
$0.10vs $0.14-28.3%
$84Mvs $83M+0.8%
Based on last 3 quarters of dataView full earnings history →

BLLN Peer Comparison

BillionToOne, Inc. (BLLN) competitors in industry — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NTRA logoNTRANatera, Inc.Direct Competitor31.4B219.23-144.2335.9%-9.05%-15.13%0.13
ILMN logoILMNIllumina, Inc.Direct Competitor25.25B166.2130.50-0.78%19.43%32.84%0.94
PGNY logoPGNYProgyny, Inc.Direct Competitor2.01B25.6539.4610.4%5.23%13.34%0.05
CDNA logoCDNACareDx, IncDirect Competitor1.22B23.66-59.1513.79%-1.98%-2.61%0.06
EXAS logoEXASExact Sciences CorporationProduct Competitor20.02B104.91-95.3717.69%-6.4%-8.66%1.05
PACB logoPACBPacific Biosciences of California, Inc.Product Competitor419.31M1.35-0.743.89%-80.34%-488.45%141.98
PRME logoPRMEPrime Medicine, Inc.Product Competitor509.34M2.82-2.0955.28%-49.18%-188.82%0.96
TMO logoTMOThermo Fisher Scientific Inc.Supply Chain176.77B475.6626.813.91%15.18%13.23%0.76

Compare BLLN vs Peers

BillionToOne, Inc. (BLLN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NTRA

Most directly comparable listed peer for BLLN.

Scale Benchmark

vs TMO

Larger-name benchmark to compare BLLN against a more recognizable public peer.

Peer Set

Compare Top 5

vs NTRA, ILMN, PGNY, CDNA

BLLN Income Statement

BillionToOne, Inc. (BLLN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'23Dec'24Dec'25TTM
Sales/Revenue
71.73M152.58M305.11M354.54M
Revenue Growth %
-112.72%99.97%-
Cost of Goods Sold
54.42M71.67M96.65M104.95M
COGS % of Revenue
75.87%46.97%31.68%-
Gross Profit
17.31M▲ 0%
80.92M▲ 367.5%
208.46M▲ 157.6%
249.58M▲ 0%
Gross Margin %
24.13%53.03%68.32%70.4%
Gross Profit Growth %
-367.5%157.63%-
Operating Expenses
86.8M128.06M192.44M213.41M
OpEx % of Revenue
121.02%83.93%63.07%-
Selling, General & Admin
64.39M91.47M143.05M159.76M
SG&A % of Revenue
89.77%59.94%46.88%-
Research & Development
22.41M36.6M49.38M53.65M
R&D % of Revenue
31.25%23.98%16.19%-
Other Operating Expenses
0000
Operating Income
-69.5M▲ 0%
-47.15M▲ 32.2%
16.02M▲ 134.0%
36.17M▲ 0%
Operating Margin %
-96.89%-30.9%5.25%10.2%
Operating Income Growth %
-32.16%133.99%-
EBITDA
-63.03M-35.46M16.02M43.86M
EBITDA Margin %
-87.88%-23.24%5.25%12.37%
EBITDA Growth %
-43.75%145.19%-
D&A (Non-Cash Add-back)
6.46M11.69M07.69M
EBIT
-79.4M-39.16M16.02M33.57M
Net Interest Income
184K3.43M7.66M10.82M
Interest Income
3.46M5.82M7.75M10.89M
Interest Expense
3.27M2.39M95K65K
Other Income/Expense
-13.18M5.61M-8.26M-6.02M
Pretax Income
-82.67M▲ 0%
-41.54M▲ 49.8%
7.76M▲ 118.7%
30.16M▲ 0%
Pretax Margin %
-115.26%-27.23%2.54%8.51%
Income Tax
9K29K305K744K
Effective Tax Rate %
-0.01%-0.07%3.93%2.47%
Net Income
-82.68M▲ 0%
-41.57M▲ 49.7%
7.45M▲ 117.9%
25.21M▲ 0%
Net Margin %
-115.27%-27.24%2.44%7.11%
Net Income Growth %
-49.72%117.93%-
Net Income (Continuing)
-82.68M-41.57M7.45M29.41M
Discontinued Operations
0000
Minority Interest
0000
EPS (Diluted)
-1.85▲ 0%
-0.93▲ 49.7%
0.06▲ 106.8%
0.48▲ 0%
EPS Growth %
-49.73%106.85%-
EPS (Basic)
-1.85-0.930.06-
Diluted Shares Outstanding
44.72M44.72M45.8M53.03M
Basic Shares Outstanding
44.72M44.72M45.8M45.93M
Dividend Payout Ratio
----

BLLN Balance Sheet

BillionToOne, Inc. (BLLN) balance sheet — assets, liabilities & shareholders' equity

MetricDec'23Dec'24Dec'25TTM
Total Current Assets
115.5M227.82M560.56M624.14M
Cash & Short-Term Investments
97.27M191.48M495.98M537.45M
Cash Only
97.27M191.48M495.98M537.45M
Short-Term Investments
0000
Accounts Receivable
9.09M24.71M41.62M61.3M
Days Sales Outstanding
46.2659.1149.7943.24
Inventory
7.2M8.73M17.55M19.22M
Days Inventory Outstanding
48.2844.4866.2659.02
Other Current Assets
1.94M2.9M5.42M6.17M
Total Non-Current Assets
76.18M74.24M72.1M76.59M
Property, Plant & Equipment
73.87M68.85M67.1M71.67M
Fixed Asset Turnover
0.97x2.22x4.55x5.18x
Goodwill
0000
Intangible Assets
0000
Long-Term Investments
0000
Other Non-Current Assets
2.31M5.39M4.99M4.92M
Total Assets
191.68M▲ 0%
302.06M▲ 57.6%
632.65M▲ 109.4%
700.73M▲ 0%
Asset Turnover
0.37x0.51x0.48x0.72x
Asset Growth %
-57.59%109.45%233.58%
Total Current Liabilities
66.8M28.39M47.96M57.16M
Accounts Payable
3.21M4.3M7.18M8.7M
Days Payables Outstanding
21.5421.9227.1327.51
Short-Term Debt
53.74M6.22M5.6M6.24M
Deferred Revenue (Current)
3.02M2.81M2.19M9.88M
Other Current Liabilities
4.26M6.64M20.44M17.56M
Current Ratio
1.73x8.03x11.69x10.92x
Quick Ratio
1.62x7.72x11.32x10.58x
Cash Conversion Cycle
7381.6688.9174.75
Total Non-Current Liabilities
94.4M105.92M104.59M137.94M
Long-Term Debt
35M51.48M57.23M90M
Capital Lease Obligations
57.6M51.68M46.07M190.33M
Deferred Tax Liabilities
0000
Other Non-Current Liabilities
1.8M2.76M00
Total Liabilities
161.2M134.31M152.55M195.11M
Total Debt
146.35M109.38M108.89M144.19M
Net Debt
49.08M-82.1M-387.08M-393.26M
Debt / Equity
4.80x0.65x0.23x0.29x
Debt / EBITDA
--6.80x3.29x
Net Debt / EBITDA
---24.16x-8.97x
Interest Coverage
-24.27x-16.41x168.66x516.43x
Total Equity
30.47M▲ 0%
167.75M▲ 450.5%
480.11M▲ 186.2%
505.62M▲ 0%
Equity Growth %
-450.48%186.2%384.66%
Book Value per Share
0.683.7510.489.53
Total Shareholders' Equity
30.47M167.75M480.11M505.62M
Common Stock
0000
Retained Earnings
-240.63M-282.2M-274.75M-256.78M
Treasury Stock
0000
Accumulated OCI
000-1.79M
Minority Interest
0000

BLLN Cash Flow Statement

BillionToOne, Inc. (BLLN) cash flow — operating, investing & free cash flow history

MetricDec'23Dec'24Dec'25TTM
Cash from Operations
-53.67M-41.38M24.59M36.22M
Operating CF Margin %
-74.83%-27.12%8.06%-
Operating CF Growth %
-22.91%159.44%228.13%
Net Income
-82.68M-41.57M2.92M25.21M
Depreciation & Amortization
6.46M11.69M11.91M10.65M
Stock-Based Compensation
0004.47M
Deferred Taxes
0000
Other Non-Cash Items
18.75M5.27M31.82M28.09M
Working Capital Changes
3.79M-16.77M-22.05M-32.96M
Change in Receivables
-2.59M-15.62M-16.91M-30.87M
Change in Inventory
-1.41M-1.53M-8.81M-5.48M
Change in Payables
151K877K1.77M149K
Cash from Investing
82.84M-5.43M-8.92M-8.17M
Capital Expenditures
-6.17M-5.4M-8.92M-8.17M
CapEx % of Revenue
8.61%3.54%2.92%2.3%
Acquisitions
0000
Investments
----
Other Investing
-988K-31K00
Cash from Financing
13.4M141.02M288.82M320.45M
Debt Issued (Net)
12.96M10.48M-1.73M29.09M
Equity Issued (Net)
444K130.53M290.55M291.36M
Dividends Paid
0000
Share Repurchases
0-546K00
Other Financing
0000
Net Change in Cash
97.27M▲ 0%
94.21M▼ 3.1%
304.5M▲ 223.2%
537.45M▲ 0%
Free Cash Flow
-59.85M▲ 0%
-46.78M▲ 21.8%
15.71M▲ 133.6%
28.09M▲ 0%
FCF Margin %
-83.43%-30.66%5.15%7.92%
FCF Growth %
-21.84%133.59%-
FCF per Share
-1.34-1.050.340.53
FCF Conversion (FCF/Net Income)
0.65x1.00x3.30x1.11x
Interest Paid
0001.29M
Taxes Paid
00016K

BLLN Key Ratios

BillionToOne, Inc. (BLLN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric20242025TTM
Return on Equity (ROE)-41.94%2.3%7.55%
Return on Invested Capital (ROIC)-42.81%13.45%28.17%
Gross Margin53.03%68.32%70.4%
Net Margin-27.24%2.44%7.11%
Debt / Equity0.65x0.23x0.29x
Interest Coverage-16.41x168.66x516.43x
FCF Conversion1.00x3.30x1.11x
Revenue Growth112.72%99.97%-
Related:BLLN Dividend History·BLLN Revenue History·BLLN Price History·BLLN P/E History·BLLN Financial Ratios·BLLN Institutional Holders

BLLN Frequently Asked Questions

BillionToOne, Inc. (BLLN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

BillionToOne, Inc. (BLLN) reported $354.5M in revenue for fiscal year 2025. This represents a 394% increase from $71.7M in 2023.

BillionToOne, Inc. (BLLN) grew revenue by 100.0% over the past year. This is strong growth.

Yes, BillionToOne, Inc. (BLLN) is profitable, generating $25.2M in net income for fiscal year 2025 (2.4% net margin).

Dividend & Returns

BillionToOne, Inc. (BLLN) has a return on equity (ROE) of 2.3%. This is below average, suggesting room for improvement.

BillionToOne, Inc. (BLLN) generated $28.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in BLLN back in 2023?

Total return calculator · dividends reinvested · 3+ years of data

See returns →

How much would $100/month in BLLN be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →